T. Rowe Price Investment Management, Inc. Cabaletta Bio, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 3,878,210 shares of CABA stock, worth $16.5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,878,210
Previous 2,470,493
56.98%
Holding current value
$16.5 Million
Previous $42.1 Million
31.17%
% of portfolio
0.02%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding CABA
# of Institutions
146Shares Held
50.2MCall Options Held
19.9KPut Options Held
41.5K-
Jennison Associates LLC5.55MShares$23.6 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.76MShares$20.3 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.04MShares$12.9 Million0.04% of portfolio
-
Alkeon Capital Management LLC New York, NY2.62MShares$11.2 Million0.03% of portfolio
-
Fred Alger Management, LLC New York, NY2.52MShares$10.7 Million0.09% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $124M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...